BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11030734)

  • 1. Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
    Mialet J; Berque-Bestel I; Sicsic S; Langlois M; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2000 Oct; 131(4):827-35. PubMed ID: 11030734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human 5-HT4(d) receptor desensitization in CHO cells.
    Mialet J; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2003 Feb; 138(3):445-52. PubMed ID: 12569069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
    Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
    Mialet J; Berque-Bestel I; Eftekhari P; Gastineau M; Giner M; Dahmoune Y; Donzeau-Gouge P; Hoebeke J; Langlois M; Sicsic S; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2000 Feb; 129(4):771-81. PubMed ID: 10683202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
    Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
    Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
    Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
    J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.
    Krobert KA; Levy FO
    Br J Pharmacol; 2002 Mar; 135(6):1563-71. PubMed ID: 11906971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes.
    Castro L; Mialet-Perez J; Guillemeau A; Stillitano F; Zolk O; Eschenhagen T; Lezoualc'h F; Bochet P; Fischmeister R
    J Mol Cell Cardiol; 2005 Aug; 39(2):335-44. PubMed ID: 15950987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
    Adham N; Zgombick JM; Bard J; Branchek TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive dimerization of human serotonin 5-HT4 receptors in living cells.
    Berthouze M; Ayoub M; Russo O; Rivail L; Sicsic S; Fischmeister R; Berque-Bestel I; Jockers R; Lezoualc'h F
    FEBS Lett; 2005 Jun; 579(14):2973-80. PubMed ID: 15896782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
    Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
    Thomas DR; Gittins SA; Collin LL; Middlemiss DN; Riley G; Hagan J; Gloger I; Ellis CE; Forbes IT; Brown AM
    Br J Pharmacol; 1998 Jul; 124(6):1300-6. PubMed ID: 9720804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i).
    Brattelid T; Kvingedal AM; Krobert KA; Andressen KW; Bach T; Hystad ME; Kaumann AJ; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):616-28. PubMed ID: 15118808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins.
    Pindon A; van Hecke G; van Gompel P; Lesage AS; Leysen JE; Jurzak M
    Mol Pharmacol; 2002 Jan; 61(1):85-96. PubMed ID: 11752209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein.
    Robert SJ; Zugaza JL; Fischmeister R; Gardier AM; Lezoualc'h F
    J Biol Chem; 2001 Nov; 276(48):44881-8. PubMed ID: 11584021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.